NIPPON EXPRESS: IATA CEIV PHARMA CERTIFICATION FOR KANSAI INTERNATIONAL AIRPORT FACILITY

KUALA LUMPUR, April 21 (Bernama) -- Nippon Express Co Ltd (Nippon Express), a group company of Nippon Express Holdings Inc has obtained IATA CEIV Pharma pharmaceutical transport quality certification, effective April 5.

The certification is for its temperature-controlled facility ‘NX-PHARMA Logistics Hub Kansai Airport’ located inside the international cargo area of Kansai International Airport, according to a statement.

Nippon Express has been participating in the KIX Pharma Community established by Kansai Airports Co Ltd and striving to acquire CEIV Pharma certification with the support of that company.

As an air cargo forwarder operating a CEIV Pharma-certified facility, Nippon Express will be providing safe and high-quality temperature-controlled transport services at Kansai International Airport.

Nippon Express obtained the same certification in March 2021 for its Narita Temperature Controlled Hub near Narita Airport and has successfully constructed a pharmaceutical distribution network connecting gateway airports in eastern and western Japan.

The ‘Nippon Express Group Business Plan 2023 - Dynamic Growth’ regards the pharmaceutical industry as a priority industry, and the NX Group has accordingly been enhancing and globally extending services to meet customer needs for increasingly sophisticated and diverse pharmaceutical logistics.

More details at https://www.nipponexpress.com/

-- BERNAMA